Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Telemedicine payment expansion?
MDedge Neurology
Epinephrine for cardiac arrest: Better survival, more brain damage
MDedge Neurology
Bundle pay plan didn’t save money
MDedge Neurology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Neurology
Is fibromyalgia one disorder – or two?
MDedge Neurology
Is fish oil’s heart benefit a fish tale?
MDedge Neurology
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Neurology
Blood pressure meds cut cognitive impairment risk
MDedge Neurology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Neurology
Free skin cancer screening highlights need
MDedge Neurology